The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial
Sign Up to like & getrecommendations! Published in 2021 at "Contemporary Clinical Trials"
DOI: 10.1016/j.cct.2021.106509
Abstract: More than 3000 clinical trials related to COVID-19 have been registered through clinicaltrials.gov. With so many trials, there is a risk that many will be inconclusive due to being underpowered or due to an inability… read more here.
Keywords: study; platform; pragmatic platform; covid outpatient ... See more keywords
D-dimer levels to exclude pulmonary embolism and reduce the need for CT angiography in COVID-19 in an outpatient population
Sign Up to like & getrecommendations! Published in 2024 at "PLOS ONE"
DOI: 10.1371/journal.pone.0297023
Abstract: Objectives Emerging results indicate that, in COVID-19, thromboembolic complications contribute to the high mortality and morbidity. Previous research showed that the prevalence of pulmonary embolism (PE) is between 25–50% in COVID-19 patients, however, most of… read more here.
Keywords: covid patients; pulmonary embolism; dimer levels; covid outpatient ... See more keywords
Implementing Early Phase Treatments for COVID-19 in Outpatient Settings: Challenges at a Tertiary Care Center in Italy and Future Outlooks
Sign Up to like & getrecommendations! Published in 2022 at "Infectious Disease Reports"
DOI: 10.3390/idr14030037
Abstract: We present a brief commentary illustrating the current COVID-19 outpatient treatment options in Italy. We also report our experience setting up a service dedicated to these patients in the wake of the rise in COVID-19… read more here.
Keywords: future outlooks; covid outpatient; care center; tertiary care ... See more keywords